Remove 2022 Remove Personality disorders Remove Sleep and mental health
article thumbnail

The 2025 Summer Heatwave: Implications for Patients With Psychiatric Disorders

Psychiatric Times

Ms Barbee has a passion to reduce the stigma around mental health and promoting increased access to mental health care and education of both clinicians and the general public. She has also served as advisory board participant for Supernus Pharmaceuticals and Axsome Therapeutics. Subscribe Now!

article thumbnail

COMP360 Psilocybin for Treatment-Resistant Depression: Positive Phase 3 Efficacy Data

Psychiatric Times

The COMP005 trial is the first phase 3 study of synthetic psilocybin, marking a milestone in psychedelic research for mental health. We remain focused on our goal of transforming the landscape of mental health treatment.” Compass Pathways plans to engage with the FDA regarding these promising preliminary results.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Tardive Dyskinesia: Treat Functional Impairment, Not the AIMS Score

Psychiatric Times

of patients who were prescribed antipsychotics for their psychiatric illness and had evidence of tardive dyskinesia (TD) had TD recorded properly in their electronic health records, supporting the idea that TD is often underreported and misdiagnosed and, therefore, not treated appropriately. References 1. Griffiths K, Won Y, Lee Z, et al.

article thumbnail

FDA Requires New Label Warning of Weight Loss Risk in Pediatric Patients Taking Extended-Release Stimulants for ADHD

Psychiatric Times

SHOW MORE The FDA will update ADHD medication labels, warning of weight loss risks in children under 6, urging careful monitoring by health care professionals. Health care professionals should monitor the child’s growth and development and provide necessary interventions to mitigate weight loss.” FDA Drug Safety Communication.

article thumbnail

How Do Psychiatry Residents Learn Psychopharmacology?

Psychiatric Times

link] Related Videos Related Content Advertisement May 29th 2025 Treatment Comparison: Somnolence/Sedation With Dopamine Partial Agonists vs D2 Receptor Antagonists Leah Kuntz April 9th 2022 Here's to a Psychedelic Revolution Amir Inamdar MBBS, DNB (Psych), MFPM May 23rd 2025 Looking Ahead to the ASCP Annual Meeting With Joseph F.

Education 123
article thumbnail

The Cat Is Out of the Bag

Mad in America

W hen I first saw Laura Delano’s story was being published by Penguin, a major publisher, I knew that we were on the brink of change by way of the public narrative around mental health in the west. But in 2022, after a major psychiatric crisis, I began to pull the threads.

article thumbnail

Clinical Pearls in Prescribing Medications for Perinatal Patients

Psychiatric Times

1 When evaluating patients, Robinson outlines that “we need to evaluate not only the risk of the medication exposure to the mother and the infant, but the very serious consideration of the untreated mental illness and those effects, which can be quite severe.”